Irinotecano ativa a via PI3-quinase/AKT/mTOR em linhagem de adenocarcinoma de colon / Chronic treatment with irinotecan activates the PI3K/AKT/mTOR pathway in HT-29 colon cancer xenografts
AUTOR(ES)
Kellen Ketty de Souza
DATA DE PUBLICAÇÃO
2007
RESUMO
Resistance of tumors to chemotherapeutic agents is a common clinical problem in human cancer. Recently, the blocking of PI3-kinase signaling pathway was shown to enhance apoptosis induced by SN-38, an active form of irinotecan. To gain further insight into the molecular events of irinotecan-associated increase in PI3-kinase signaling pathway, aspirin and rapamycin were used to modulate this signaling pathway. We describe here that aspirin is able to further inhibit IRS-l serine phosphorylation induced by irinotecan through targeting JNK and IKK, thus agonist activation of IRS-l/PI3-kinase pathway blocked the growth-inhibitory effect of irinotecan in HT -29 colon cancer xenografts; our data also demonstrate a synergistic effect of mTOR inhibition and irinotecan on tumor growth. Activation of PI3-kinase/ Akt/mTOR pathway may thus contribute to refTactoriness to treatment with irinotecan
ASSUNTO(S)
colonic neoplasms camptothecin neoplasias do colon camptotecina aspirina aspirin
ACESSO AO ARTIGO
http://libdigi.unicamp.br/document/?code=vtls000429117Documentos Relacionados
- Long non-coding RNA HOTAIR induces the PI3K/AKT/mTOR signaling pathway in breast cancer cells
- Efeito do paclitaxel na via IRS/PI3K/Akt/mTOR em linhagem de adenocarcinoma de mama e carcinoma de pulmão
- Insulin Promotes the Expression of the Gluconeogenic Rate-Limiting Enzymes Phosphoenolpyruvate Carboxykinase (Pepck) and Glucose 6-Phosphatase (G6pase) through PI3k/Akt/mTOR Signaling Pathway in Goose Hepatocytes
- Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
- Avaliação da eficácia da Terapia Fotodinâmica mediada pela alumínio cloro ftalocianina - AlPHCl - lipossomal no tratamento de células derivadas do câncer bucal e sua atuação na regulação da via de sinalização PI3K/AKT/mTOR